DNATRIX INC;BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
发明人:
申请号：
IL24321515
公开号：
IL243215D0
申请日:
2015.12.17
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The present disclosure involves compositions and methods for treating brain cancers having mutations in the retinoblastoma (Rb) pathway using an oncolytic adenovirus comprising an alteration in the Rb binding site of E1A, and a targeting motif inserted in the Ad fiber protein. The adenovirus is able to kill the tumor cells without harming cells with a wild-type retinoblastoma pathway.
